B. 1. Calkins, H. Kuck, K. Cappato, R. Brugada, J. Camm et al., 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society, Europace, vol.32, issue.2, pp.528-606, 2012.
DOI : 10.1016/j.amjcard.2005.09.063

A. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva et al., Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc), Europace, vol.12, pp.1360-1420, 2010.

F. Hobbs, D. Fitzmaurice, J. Mant, E. Murray, S. Jowett et al., A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study, Health Technology Assessment, vol.9, issue.40, pp.1-74, 2005.
DOI : 10.3310/hta9400

P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm et al., Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association, Europace, vol.9, issue.11, pp.1006-1023, 2007.
DOI : 10.1093/europace/eum191

S. Kopecky, B. Gersh, M. Mcgoon, J. Whisnant, D. Holmes et al., The Natural History of Lone Atrial Fibrillation, New England Journal of Medicine, vol.317, issue.11, pp.669-674, 1987.
DOI : 10.1056/NEJM198709103171104

A. Go, E. Hylek, K. Phillips, Y. Chang, L. Henault et al., Prevalence of Diagnosed Atrial Fibrillation in Adults, JAMA, vol.285, issue.18, pp.2370-2375, 2001.
DOI : 10.1001/jama.285.18.2370

A. Charlemagne, J. Blacher, A. Cohen, J. Collet, F. Dievart et al., Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Archives of Cardiovascular Diseases, vol.104, issue.2, pp.115-124, 2011.
DOI : 10.1016/j.acvd.2010.11.012

L. , D. Wang, T. Leip, E. Larson, M. Levy et al., Lifetime risk for development of atrial fibrillation: The framingham heart study, Circulation, vol.110, pp.1042-1046, 2004.

G. Naccarelli, H. Varker, J. Lin, and K. Schulman, Increasing Prevalence of Atrial Fibrillation and Flutter in the United States, The American Journal of Cardiology, vol.104, issue.11, pp.1534-1539, 2009.
DOI : 10.1016/j.amjcard.2009.07.022

Y. Miyasaka, M. Barnes, B. Gersh, S. Cha, K. Bailey et al., Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence, Circulation, vol.114, issue.2, pp.119-125, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.595140

T. Wang, M. Larson, D. Levy, R. Vasan, E. Leip et al., Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study, Circulation, vol.107, issue.23, pp.2920-2925, 2003.
DOI : 10.1161/01.CIR.0000072767.89944.6E

R. Nieuwlaat, A. Capucci, A. Camm, S. Olsson, D. Andresen et al., Atrial fibrillation management: a prospective survey in ESC Member Countries, European Heart Journal, vol.26, issue.22, pp.2422-2434, 2005.
DOI : 10.1186/1471-2261-4-18

M. Nabauer, A. Gerth, T. Limbourg, S. Schneider, M. Oeff et al., The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management, Europace, vol.285, issue.22, pp.423-434, 2009.
DOI : 10.1001/jama.285.22.2864

B. Maron, J. Towbin, G. Thiene, C. Antzelevitch, D. Corrado et al., Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention, Circulation, vol.113, issue.14, pp.1807-1816, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.174287

T. Wang, H. Parise, D. Levy, D. Agostino, R. Sr et al., Obesity and the Risk of New-Onset Atrial Fibrillation, JAMA, vol.292, issue.20, pp.2471-2477, 2004.
DOI : 10.1001/jama.292.20.2471

A. Gami, D. Hodge, R. Herges, E. Olson, J. Nykodym et al., Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial Fibrillation, Journal of the American College of Cardiology, vol.49, issue.5, pp.565-571, 2007.
DOI : 10.1016/j.jacc.2006.08.060

F. Bisbal and L. Mont, Arrhythmias in the athlete, Herzschrittmacherther Elektrophysiol, vol.23, pp.76-81, 2012.

A. Pelliccia, B. Maron, D. Paolo, F. Biffi, A. Quattrini et al., Prevalence and Clinical Significance of Left Atrial Remodeling in Competitive Athletes, Journal of the American College of Cardiology, vol.46, issue.4, pp.690-696, 2005.
DOI : 10.1016/j.jacc.2005.04.052

L. Molina, L. Mont, J. Marrugat, A. Berruezo, J. Brugada et al., Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study, EP Europace, vol.137, issue.5, pp.618-623, 2008.
DOI : 10.1016/S0002-8703(99)70481-3

J. Abdulla and J. Nielsen, Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis, Europace, vol.103, issue.11, pp.1156-1159, 2009.
DOI : 10.1016/j.amjcard.2009.01.374

L. Heuzey, J. Paziaud, O. Piot, O. Said, M. Copie et al., Cost of care distribution in atrial fibrillation patients: the COCAF study, American Heart Journal, vol.147, issue.1, pp.121-126, 2004.
DOI : 10.1016/S0002-8703(03)00524-6

E. Benjamin, P. Wolf, D. Agostino, R. Silbershatz, H. Kannel et al., Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study, Circulation, vol.98, issue.10, pp.946-952, 1998.
DOI : 10.1161/01.CIR.98.10.946

X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere, Idiopathic atrial fibrillation as a risk factor for mortality.The Paris Prospective Study I, European Heart Journal, vol.20, issue.12, pp.896-899, 1999.
DOI : 10.1053/euhj.1998.1397

B. Gage, A. Waterman, W. Shannon, M. Boechler, M. Rich et al., Validation of Clinical Classification Schemes for Predicting Stroke, JAMA, vol.285, issue.22, pp.2864-2870, 2001.
DOI : 10.1001/jama.285.22.2864

R. Hart, L. Pearce, and M. Aguilar, Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation, Annals of Internal Medicine, vol.146, issue.12, pp.857-867, 2007.
DOI : 10.7326/0003-4819-146-12-200706190-00007

S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren et al., Dabigatran versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.361, issue.12, pp.1139-1151, 2009.
DOI : 10.1056/NEJMoa0905561

M. Patel, K. Mahaffey, J. Garg, G. Pan, D. Singer et al., Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.10, pp.883-891, 2011.
DOI : 10.1056/NEJMoa1009638

URL : https://hal.archives-ouvertes.fr/hal-01038111

V. Shevelev and S. Kanorskii, [comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation], Kardiologiia, vol.52, pp.56-60, 2012.

M. Kaarisalo, P. Immonen-raiha, R. Marttila, V. Salomaa, E. Kaarsalo et al., Atrial Fibrillation and Stroke: Mortality and Causes of Death After the First Acute Ischemic Stroke, Stroke, vol.28, issue.2, pp.311-315, 1997.
DOI : 10.1161/01.STR.28.2.311

Y. Miyasaka, M. Barnes, B. Gersh, S. Cha, J. Seward et al., Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study, Stroke, vol.36, issue.11, pp.2362-2366, 1980.
DOI : 10.1161/01.STR.0000185927.63746.23

G. Lip and D. Beevers, ABC of Atrial Fibrillation: HISTORY, EPIDEMIOLOGY, AND IMPORTANCE OF ATRIAL FIBRILLATION, BMJ, vol.311, issue.7016, pp.1361-1363, 1995.
DOI : 10.1136/bmj.311.7016.1361

G. Moe, W. Rheinboldt, and J. Abildskov, A computer model of atrial fibrillation, American Heart Journal, vol.67, issue.2, pp.200-220, 1964.
DOI : 10.1016/0002-8703(64)90371-0

M. Allessie, . Lw, F. Bonke, and J. Hollen, Experimental evaluation of moe's multiple wavelet hypothesis of atrial fibrillation -in: Zipes dp, jalife j, eds. Cariac Arrhythmias, pp.265-276, 1985.

K. Konings, C. Kirchhof, J. Smeets, H. Wellens, O. Penn et al., High-density mapping of electrically induced atrial fibrillation in humans, Circulation, vol.89, issue.4, pp.1665-1680, 1994.
DOI : 10.1161/01.CIR.89.4.1665

P. Attuel, R. Childers, B. Cauchemez, J. Poveda, J. Mugica et al., Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability, International Journal of Cardiology, vol.2, issue.2, pp.179-197, 1982.
DOI : 10.1016/0167-5273(82)90032-8

L. Heuzey, J. Copie, X. Henry, P. Halimi, F. Lavergne et al., [mechanisms of atrial fibrillation: Recent advances], Arch Mal Coeur Vaiss, vol.87, issue.3, pp.41-45, 1994.

M. Wijffels, C. Kirchhof, R. Dorland, and M. Allessie, Atrial Fibrillation Begets Atrial Fibrillation : A Study in Awake Chronically Instrumented Goats, Circulation, vol.92, issue.7, pp.1954-1968, 1995.
DOI : 10.1161/01.CIR.92.7.1954

B. Brundel, R. Henning, H. Kampinga, V. Gelder, I. Crijns et al., Molecular mechanisms of remodeling in human atrial fibrillation, Cardiovascular Research, vol.54, issue.2, pp.315-324, 2002.
DOI : 10.1016/S0008-6363(02)00222-5

P. Kojodjojo, N. Peters, D. Davies, and P. Kanagaratnam, Characterization of the Electroanatomical Substrate in Human Atrial Fibrillation: The Relationship between Changes in Atrial Volume, Refractoriness, Wavefront Propagation Velocities, and AF Burden, Journal of Cardiovascular Electrophysiology, vol.103, issue.3, pp.269-275, 2007.
DOI : 10.1016/0002-8703(59)90126-7

A. Goette and U. Lendeckel, Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms, Europace, vol.10, issue.2, pp.238-241, 2008.
DOI : 10.1093/europace/eum283

K. Murray, J. Rottman, P. Arbogast, L. Shemanski, R. Primm et al., Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM, Heart Rhythm, vol.1, issue.6, pp.669-675, 2004.
DOI : 10.1016/j.hrthm.2004.08.008

I. Savelieva and A. Camm, Upstream therapies after pulmonary vein ablation: five negative studies--what's next?, Europace, vol.381, issue.3, pp.1509-1513, 2010.
DOI : 10.1056/NEJMoa0805710

URL : https://academic.oup.com/europace/article-pdf/12/12/1799/7276189/euq440.pdf

I. Savelieva, N. Kakouros, A. Kourliouros, and A. Camm, Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention, Europace, vol.125, issue.3, pp.610-625, 2011.
DOI : 10.1016/j.ijcard.2006.12.063

A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M. Russo et al., Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation, Circulation, vol.96, issue.4, pp.1180-1184, 1997.
DOI : 10.1161/01.CIR.96.4.1180

L. Armaganijan, D. Patel, R. Lopes, C. Morillo, R. Araujo et al., Gastroesophageal reflux and atrial fibrillation: is there any correlation?, Expert Review of Cardiovascular Therapy, vol.102, issue.3, pp.317-322, 2012.
DOI : 10.1016/j.amjcard.2008.06.048

J. Kunz, B. Hemann, E. Atwood, J. Jackson, J. Wu et al., Is There a Link Between Gastroesophageal Reflux Disease and Atrial Fibrillation?, Clinical Cardiology, vol.102, issue.10, pp.584-587, 2009.
DOI : 10.1161/01.CIR.96.4.1180

T. Bunch, D. Packer, A. Jahangir, G. Locke, N. Talley et al., Long-Term Risk of Atrial Fibrillation With Symptomatic Gastroesophageal Reflux Disease and Esophagitis, The American Journal of Cardiology, vol.102, issue.9, pp.1207-1211, 2008.
DOI : 10.1016/j.amjcard.2008.06.048

H. Shimazu, G. Nakaji, M. Fukata, K. Odashiro, T. Maruyama et al., Relationship between Atrial Fibrillation and Gastroesophageal Reflux Disease: A Multicenter Questionnaire Survey, Cardiology, vol.54, issue.4, pp.217-223, 2011.
DOI : 10.1016/j.jjcc.2009.04.002

P. Velagapudi, M. Turagam, M. Leal, and A. Kocheril, Atrial Fibrillation and Acid Reflux Disease, Clinical Cardiology, vol.291, issue.3, pp.180-186, 2012.
DOI : 10.1001/jama.291.23.2851

M. Weigl, M. Gschwantler, E. Gatterer, J. Finsterer, and C. Stollberger, Reflux Esophagitis in the Pathogenesis of Paroxysmal Atrial Fibrillation: Results of a Pilot Study, Southern Medical Journal, vol.96, issue.11, pp.1128-1132, 2003.
DOI : 10.1097/01.SMJ.0000084294.77504.4B

H. Nakamura, G. Nakaji, H. Shimazu, S. Yasuda, K. Odashiro et al., Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis, Fukuoka Igaku Zasshi, vol.98, pp.270-276, 2007.

M. Haissaguerre, P. Jais, D. Shah, A. Takahashi, M. Hocini et al., Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins, New England Journal of Medicine, vol.339, issue.10, pp.659-666, 1998.
DOI : 10.1056/NEJM199809033391003

M. Haissaguerre, F. Marcus, B. Fischer, and J. Clementy, Radiofrequency Catheter Ablation in Unusual Mechanisms of Atrial Fibrillation:., Journal of Cardiovascular Electrophysiology, vol.17, issue.9, pp.743-751, 1994.
DOI : 10.1161/01.CIR.89.4.1665

P. Jais, M. Haissaguerre, D. Shah, S. Chouairi, L. Gencel et al., A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation, Circulation, vol.95, issue.3, pp.572-576, 1997.
DOI : 10.1161/01.CIR.95.3.572

S. Webb, M. Kanani, R. Anderson, M. Richardson, and N. Brown, Development of the human pulmonary vein and its incorporation in the morphologically left atrium, Cardiology in the Young, vol.11, issue.06, pp.632-642, 2001.
DOI : 10.1017/S1047951101000993

D. Zipes and R. Knope, Electrical properties of the thoracic veins, The American Journal of Cardiology, vol.29, issue.3, pp.372-376, 1972.
DOI : 10.1016/0002-9149(72)90533-4

Y. Chen, N. Pan, C. Cheng, S. Higa, Y. Chen et al., Heterogeneous Expression of Potassium Currents and Pacemaker Currents Potentially Regulates Arrhythmogenesis of Pulmonary Vein Cardiomyocytes, Journal of Cardiovascular Electrophysiology, vol.98, issue.9, pp.1039-1045, 2009.
DOI : 10.1161/01.RES.82.9.947

H. Honjo, M. Boyett, R. Niwa, S. Inada, M. Yamamoto et al., Pacing-Induced Spontaneous Activity in Myocardial Sleeves of Pulmonary Veins After Treatment With Ryanodine, Circulation, vol.107, issue.14, pp.1937-1943, 2003.
DOI : 10.1161/01.CIR.0000062645.38670.BD

W. Wongcharoen, Y. Chen, Y. Chen, C. Chang, H. Yeh et al., Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity, Cardiovascular Research, vol.70, issue.3, pp.497-508, 2006.
DOI : 10.1016/j.cardiores.2006.02.026

M. Levin, M. Lu, N. Petrenko, B. Hawkins, T. Gupta et al., Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers, Journal of Clinical Investigation, vol.119, pp.3420-3436, 2009.
DOI : 10.1172/JCI39109DS1

J. Ehrlich, T. Cha, L. Zhang, D. Chartier, P. Melnyk et al., Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties, The Journal of Physiology, vol.551, issue.3, pp.801-813, 2003.
DOI : 10.1113/jphysiol.2003.046417

A. Perez-lugones, J. Mcmahon, N. Ratliff, W. Saliba, R. Schweikert et al., Evidence of Specialized Conduction Cells in Human Pulmonary Veins of Patients with Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, vol.105, issue.Suppl II, pp.803-809, 2003.
DOI : 10.1161/01.CIR.0000016822.96362.26

M. Hocini, S. Ho, T. Kawara, A. Linnenbank, M. Potse et al., Electrical Conduction in Canine Pulmonary Veins: Electrophysiological and Anatomic Correlation, Circulation, vol.105, issue.20, pp.2442-2448, 2002.
DOI : 10.1161/01.CIR.0000016062.80020.11

J. Kalifa, J. Jalife, A. Zaitsev, S. Bagwe, M. Warren et al., Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation, Circulation, vol.108, issue.6, pp.668-671, 2003.
DOI : 10.1161/01.CIR.0000086979.39843.7B

K. Kumagai, M. Ogawa, H. Noguchi, T. Yasuda, H. Nakashima et al., Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter, Journal of the American College of Cardiology, vol.43, issue.12, pp.2281-2289, 2004.
DOI : 10.1016/j.jacc.2004.01.051

S. Nattel, Basic Electrophysiology of the Pulmonary Veins and Their Role in Atrial Fibrillation:. Precipitators, Perpetuators, and Perplexers, Journal of Cardiovascular Electrophysiology, vol.100, issue.3, pp.1372-1375, 2003.
DOI : 10.1016/S0894-7317(03)00421-8

M. Haissaguerre, P. Sanders, M. Hocini, L. Hsu, D. Shah et al., Changes in Atrial Fibrillation Cycle Length and Inducibility During Catheter Ablation and Their Relation to Outcome, Circulation, vol.109, issue.24, pp.3007-3013, 2004.
DOI : 10.1161/01.CIR.0000130645.95357.97

K. Nademanee, J. Mckenzie, E. Kosar, M. Schwab, B. Sunsaneewitayakul et al., A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate, Journal of the American College of Cardiology, vol.43, issue.11, pp.2044-2053, 2004.
DOI : 10.1016/j.jacc.2003.12.054

J. Kalifa, K. Tanaka, A. Zaitsev, M. Warren, R. Vaidyanathan et al., Mechanisms of Wave Fractionation at Boundaries of High-Frequency Excitation in the Posterior Left Atrium of the Isolated Sheep Heart During Atrial Fibrillation, Circulation, vol.113, issue.5, pp.626-633, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.575340

F. Atienza and J. Jalife, Reentry and atrial fibrillation, Heart Rhythm, vol.4, issue.3, pp.13-16, 2007.
DOI : 10.1016/j.hrthm.2006.12.004

J. Jalife, O. Berenfeld, and M. Mansour, Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation, Cardiovascular Research, vol.54, issue.2, pp.204-216, 2002.
DOI : 10.1016/S0008-6363(02)00223-7

P. Coumel, Autonomic Influences in Atrial Tachyarrhythmias, Journal of Cardiovascular Electrophysiology, vol.4, issue.10, pp.999-1007, 1996.
DOI : 10.1007/978-94-011-1816-3_12

H. Otake, H. Suzuki, T. Honda, and Y. Maruyama, Influences of Autonomic Nervous System on Atrial Arrhythmogenic Substrates and the Incidence of Atrial Fibrillation in Diabetic Heart, International Heart Journal, vol.50, issue.5, pp.627-641, 2009.
DOI : 10.1536/ihj.50.627

H. Park, M. Shen, S. Lin, M. Fishbein, L. Chen et al., Neural mechanisms of atrial fibrillation, Current Opinion in Cardiology, vol.27, issue.1, pp.24-28, 2012.
DOI : 10.1097/HCO.0b013e32834dc4e8

P. Coumel, paroxysmal atrial fibrillation: Role of autonomic nervous system]. Arch Mal Coeur Vaiss, pp.55-62, 1994.

B. He, B. Scherlag, H. Nakagawa, R. Lazzara, and S. Po, The Intrinsic Autonomic Nervous System in Atrial Fibrillation: A Review, ISRN Cardiology, vol.9, issue.5, p.490674, 2012.
DOI : 10.1016/j.yjmcc.2008.07.015

O. Sharifov, V. Fedorov, G. Beloshapko, A. Glukhov, A. Yushmanova et al., Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs, Journal of the American College of Cardiology, vol.43, issue.3, pp.483-490, 2004.
DOI : 10.1016/j.jacc.2003.09.030

M. Bettoni and M. Zimmermann, Autonomic Tone Variations Before the Onset of Paroxysmal Atrial Fibrillation, Circulation, vol.105, issue.23, pp.2753-2759, 2002.
DOI : 10.1161/01.CIR.0000018443.44005.D8

A. Elvan, H. Pride, J. Eble, and D. Zipes, Radiofrequency Catheter Ablation of the Atria Reduces Inducibility and Duration of Atrial Fibrillation in Dogs, Circulation, vol.91, issue.8, pp.2235-2244, 1995.
DOI : 10.1161/01.CIR.91.8.2235

C. Chang, T. Wu, S. Zhou, R. Doshi, M. Lee et al., Nerve Sprouting and Sympathetic Hyperinnervation in a Canine Model of Atrial Fibrillation Produced by Prolonged Right Atrial Pacing, Circulation, vol.103, issue.1, pp.22-25, 2001.
DOI : 10.1161/01.CIR.103.1.22

D. Clark, V. Plumb, A. Epstein, and G. Kay, Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation, Journal of the American College of Cardiology, vol.30, issue.4, pp.1039-1045, 1997.
DOI : 10.1016/S0735-1097(97)00254-4

G. Gronefeld, J. Lilienthal, K. Kuck, and S. Hohnloser, Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillationResults from a prospective randomized study, European Heart Journal, vol.24, issue.15, pp.1430-1436, 2003.
DOI : 10.1016/S0195-668X(03)00261-6

I. Van-gelder, V. Hagens, H. Bosker, J. Kingma, O. Kamp et al., A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation, New England Journal of Medicine, vol.347, issue.23, pp.1834-1840, 2002.
DOI : 10.1056/NEJMoa021375

J. Carlsson, S. Miketic, J. Windeler, A. Cuneo, S. Haun et al., Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation, Journal of the American College of Cardiology, vol.41, issue.10, pp.1690-1696, 2003.
DOI : 10.1016/S0735-1097(03)00332-2

G. Opolski, A. Torbicki, D. Kosior, M. Szulc, B. Wozakowska-kaplon et al., Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation, Chest, vol.126, issue.2, pp.476-486, 2004.
DOI : 10.1378/chest.126.2.476

D. Wyse, A. Waldo, J. Dimarco, M. Domanski, Y. Rosenberg et al., A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, vol.347, pp.1825-1833, 2002.

S. Ogawa, T. Yamashita, T. Yamazaki, Y. Aizawa, H. Atarashi et al., Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation, Circulation Journal, vol.73, issue.2, pp.242-248, 2009.
DOI : 10.1253/circj.CJ-08-0608

S. Coplen, E. Antman, J. Berlin, P. Hewitt, and T. Chalmers, Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials [published erratum appears in Circulation 1991 Feb;83(2):714], Circulation, vol.82, issue.4, pp.1106-1116, 1990.
DOI : 10.1161/01.CIR.82.4.1106

D. Roy, M. Talajic, P. Dorian, S. Connolly, M. Eisenberg et al., Amiodarone to Prevent Recurrence of Atrial Fibrillation, New England Journal of Medicine, vol.342, issue.13, pp.913-920, 2000.
DOI : 10.1056/NEJM200003303421302

B. Karlson, I. Torstensson, C. Abjorn, S. Jansson, and L. Peterson, Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study, European Heart Journal, vol.9, issue.3, pp.284-290, 1988.
DOI : 10.1093/oxfordjournals.eurheartj.a062498

J. Anderson, E. Gilbert, B. Alpert, R. Henthorn, A. Waldo et al., Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group, Circulation, vol.80, issue.6, pp.1557-1570, 1989.
DOI : 10.1161/01.CIR.80.6.1557

D. Echt, P. Liebson, L. Mitchell, R. Peters, D. Obias-manno et al., Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo, New England Journal of Medicine, vol.324, issue.12, pp.781-788, 1991.
DOI : 10.1056/NEJM199103213241201

E. Aliot, A. Capucci, H. Crijns, A. Goette, and J. Tamargo, Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation, Europace, vol.74, issue.8, pp.161-173, 2011.
DOI : 10.1016/0002-9149(94)90448-0

S. Reimold, C. Cantillon, P. Friedman, and E. Antman, Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation, The American Journal of Cardiology, vol.71, issue.7, pp.558-563, 1993.
DOI : 10.1016/0002-9149(93)90511-A

S. Hammill, D. Wood, B. Gersh, M. Osborn, D. Holmes et al., Propafenone for paroxysmal atrial fibrillation, The American Journal of Cardiology, vol.61, issue.6, pp.473-474, 1988.
DOI : 10.1016/0002-9149(88)90312-8

S. Connolly, H. Crijns, C. Torp-pedersen, M. Van-eickels, C. Gaudin et al., Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter, Circulation, vol.120, issue.13, pp.1174-1180, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.875252

S. Saksena, A. Slee, A. Waldo, N. Freemantle, M. Reynolds et al., Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management), Journal of the American College of Cardiology, vol.58, issue.19, pp.1975-1985, 2011.
DOI : 10.1016/j.jacc.2011.07.036

S. Connolly, A. Camm, J. Halperin, C. Joyner, M. Alings et al., Dronedarone in High-Risk Permanent Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.24, pp.2268-2276, 2011.
DOI : 10.1056/NEJMoa1109867

J. Healey, W. Toff, G. Lamas, H. Andersen, K. Thorpe et al., Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data, Circulation, vol.114, issue.1, pp.11-17, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.610303

B. Knight, B. Gersh, M. Carlson, P. Friedman, R. Mcnamara et al., Role of Permanent Pacing to Prevent Atrial Fibrillation: Science Advisory From the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society, Circulation, vol.111, issue.2, pp.240-243, 2005.
DOI : 10.1161/01.CIR.0000151800.84945.47

I. Van-gelder, H. Groenveld, H. Crijns, Y. Tuininga, J. Tijssen et al., Lenient versus Strict Rate Control in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.362, issue.15, pp.1363-1373, 2010.
DOI : 10.1056/NEJMoa1001337

L. Harrison, J. Gallagher, J. Kasell, R. Anderson, E. Mikat et al., Cryosurgical ablation of the A-V node-His bundle: a new method for producing A-V block, Circulation, vol.55, issue.3, pp.463-470, 1977.
DOI : 10.1161/01.CIR.55.3.463

J. Gallagher, R. Svenson, J. Kasell, L. German, G. Bardy et al., Catheter Technique for Closed-Chest Ablation of the Atrioventricular Conduction System, New England Journal of Medicine, vol.306, issue.4, pp.194-200, 1982.
DOI : 10.1056/NEJM198201283060402

C. Ozcan, A. Jahangir, P. Friedman, P. Patel, T. Munger et al., Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.344, issue.14, pp.1043-1051, 2001.
DOI : 10.1056/NEJM200104053441403

M. Brignole, C. Menozzi, L. Gianfranchi, G. Musso, R. Mureddu et al., Assessment of Atrioventricular Junction Ablation and VVIR Pacemaker Versus Pharmacological Treatment in Patients With Heart Failure and Chronic Atrial Fibrillation : A Randomized, Controlled Study, Circulation, vol.98, issue.10, pp.953-960, 1998.
DOI : 10.1161/01.CIR.98.10.953

R. Doshi, E. Daoud, C. Fellows, K. Turk, A. Duran et al., Left Ventricular-Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study), Journal of Cardiovascular Electrophysiology, vol.136, issue.11, pp.1160-1165, 2005.
DOI : 10.1056/NEJM200104053441403

C. Carbucicchio, F. Lavarra, S. Riva, G. Fassini, D. Bella et al., [modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results], Cardiologia, vol.40, pp.927-940, 1995.

J. Cox, T. Canavan, R. Schuessler, M. Cain, B. Lindsay et al., The surgical treatment of atrial fibrillation. Ii. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation, J Thorac Cardiovasc Surg, vol.101, pp.406-426, 1991.

J. Cox, Atrial fibrillation I: a new classification system, The Journal of Thoracic and Cardiovascular Surgery, vol.126, issue.6, pp.1686-1692, 2003.
DOI : 10.1016/j.jtcvs.2003.06.002

J. Cox, Atrial fibrillation II: rationale for surgical treatment, The Journal of Thoracic and Cardiovascular Surgery, vol.126, issue.6, pp.1693-1699, 2003.
DOI : 10.1016/j.jtcvs.2003.06.003

J. Cox, Surgical treatment of atrial fibrillation: a review, Europace, vol.5, issue.1, pp.20-29, 2004.
DOI : 10.1016/j.eupc.2004.07.004

R. Damiano, J. Gaynor, S. Bailey, M. Prasad, S. Cox et al., The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the cox maze procedure, The Journal of Thoracic and Cardiovascular Surgery, vol.126, issue.6, pp.2016-2021, 2003.
DOI : 10.1016/j.jtcvs.2003.07.006

S. Prasad, H. Maniar, C. Camillo, R. Schuessler, J. Boineau et al., The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures, The Journal of Thoracic and Cardiovascular Surgery, vol.126, issue.6, pp.1822-1828, 2003.
DOI : 10.1016/S0022-5223(03)01287-X

J. Defauw, G. Guiraudon, N. Van-hemel, F. Vermeulen, J. Kingma et al., Surgical therapy of paroxysmal atrial fibrillation with the ???corridor??? operation, The Annals of Thoracic Surgery, vol.53, issue.4, pp.564-570, 1992.
DOI : 10.1016/0003-4975(92)90312-R

N. Van-hemel, J. Defauw, J. Kingma, W. Jaarsma, F. Vermeulen et al., Long-term results of the corridor operation for atrial fibrillation., Heart, vol.71, issue.2, pp.170-176, 1994.
DOI : 10.1136/hrt.71.2.170

R. Lee, J. Kruse, and P. Mccarthy, Surgery for atrial fibrillation, Nature Reviews Cardiology, vol.83, issue.8, pp.505-513, 2009.
DOI : 10.1016/j.jtcvs.2005.05.014

J. Melo, P. Adragao, J. Neves, M. Ferreira, A. Timoteo et al., Endocardial and epicardial radiofrequency ablation in the treatment of atrial fibrillation with a new intra-operative device???, European Journal of Cardio-Thoracic Surgery, vol.60, issue.2, pp.182-186, 2000.
DOI : 10.1016/0003-4975(95)00314-B

K. Imai, T. Sueda, K. Orihashi, M. Watari, and Y. Matsuura, Clinical analysis of results of a simple left atrial procedure for chronic atrial fibrillation, The Annals of Thoracic Surgery, vol.71, issue.2, pp.577-581, 2001.
DOI : 10.1016/S0003-4975(00)02254-2

J. Melo, P. Adragao, J. Neves, M. Ferreira, M. Calquinha et al., [surgery of atrial fibrillation with intraoperative radiofrequency], Rev Port Cardiol, vol.20, issue.5, pp.189-191193, 2001.

T. Sueda, K. Imai, K. Orihashi, M. Watari, and K. Okada, Pulmonary vein orifice isolation for elimination of chronic atrial fibrillation, The Annals of Thoracic Surgery, vol.71, issue.2, pp.708-710, 2001.
DOI : 10.1016/S0003-4975(00)02014-2

H. Kottkamp, G. Hindricks, R. Autschbach, B. Krauss, B. Strasser et al., Specific linear left atrial lesions in atrial fibrillation, Journal of the American College of Cardiology, vol.40, issue.3, pp.475-480, 2002.
DOI : 10.1016/S0735-1097(02)01993-9

J. Maessen, J. Nijs, J. Smeets, J. Vainer, and B. Mochtar, Beating-heart surgical treatment of atrial fibrillation with microwave ablation, The Annals of Thoracic Surgery, vol.74, issue.4, pp.1307-1311, 2002.
DOI : 10.1016/S0003-4975(02)03908-5

J. Ninet, X. Roques, R. Seitelberger, C. Deville, J. Pomar et al., Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: Results of a multicenter trial, The Journal of Thoracic and Cardiovascular Surgery, vol.130, issue.3, pp.803-809, 2005.
DOI : 10.1016/j.jtcvs.2005.05.014

N. Saoudi, D. Mouton-schleiffer, and B. Letac, DIRECT CATHETER FULGURATION OF ATRIAL FLUTTER, The Lancet, vol.330, issue.8558, pp.568-569, 1987.
DOI : 10.1016/S0140-6736(87)92953-9

D. Packer, S. Asirvatham, and T. Munger, Progress in Nonpharmacologic Therapy of Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, vol.101, issue.10, pp.296-309, 2003.
DOI : 10.1056/NEJM200104053441403

M. Haissaguerre, P. Jais, D. Shah, L. Gencel, V. Pradeau et al., Right and Left Atrial Radiofrequency Catheter Therapy of Paroxysmal Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, vol.19, issue.11, pp.1132-1144, 1996.
DOI : 10.1016/0895-4356(88)90101-1

P. Jais, D. Shah, M. Haissaguerre, A. Takahashi, T. Lavergne et al., Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation Mapping and ablation of left atrial flutters, Am J Cardiol. Circulation, vol.84101, pp.2928-2934, 1999.

C. Pappone, G. Oreto, F. Lamberti, G. Vicedomini, M. Loricchio et al., Catheter Ablation of Paroxysmal Atrial Fibrillation Using a 3D Mapping System, Circulation, vol.100, issue.11, pp.1203-1208, 1999.
DOI : 10.1161/01.CIR.100.11.1203

M. Haissaguerre, D. Shah, P. Jais, M. Hocini, T. Yamane et al., Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins, Circulation, vol.102, issue.20, pp.2463-2465, 2000.
DOI : 10.1161/01.CIR.102.20.2463

M. Haissaguerre, P. Jais, D. Shah, S. Garrigue, A. Takahashi et al., Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci, Circulation, vol.101, issue.12, pp.1409-1417, 2000.
DOI : 10.1161/01.CIR.101.12.1409

C. Pappone, G. Oreto, S. Rosanio, G. Vicedomini, M. Tocchi et al., Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation, Circulation, vol.104, issue.21, pp.2539-2544, 2001.
DOI : 10.1161/hc4601.098517

C. Pappone, S. Rosanio, G. Oreto, M. Tocchi, F. Gugliotta et al., [prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia], Recenti Prog Med, vol.92, pp.508-512, 2001.

C. Pappone, V. Santinelli, F. Manguso, G. Vicedomini, F. Gugliotta et al., Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation, Circulation, vol.109, issue.3, pp.327-334, 2004.
DOI : 10.1161/01.CIR.0000112641.16340.C7

N. Marrouche, R. Schweikert, W. Saliba, S. Pavia, D. Martin et al., Use of Different Catheter Ablation Technologies for Treatment of Typical Atrial Flutter:., Pacing and Clinical Electrophysiology, vol.104, issue.3, pp.743-746, 2003.
DOI : 10.1161/01.CIR.89.3.1074

P. Adragao, D. Cavaco, C. Aguiar, J. Palos, F. Morgado et al., Ablation of pulmonary vein foci for the treatment of atrial fibrillation. Percutaneous electroanatomical guided approach, Europace, vol.4, issue.4, pp.391-399, 2002.
DOI : 10.1053/eupc.2002.0257

C. Pappone and V. Santinelli, Atrial Fibrillation Ablation: How Far Have We Come?, Revista Espa??ola de Cardiolog??a (English Edition), vol.62, issue.10, pp.1087-1091, 2009.
DOI : 10.1016/S1885-5857(09)73321-3

C. Pappone, S. Rosanio, G. Augello, G. Gallus, G. Vicedomini et al., Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation, Journal of the American College of Cardiology, vol.42, issue.2, pp.185-197, 2003.
DOI : 10.1016/S0735-1097(03)00577-1

M. Hocini, P. Jais, P. Sanders, Y. Takahashi, M. Rotter et al., Techniques, Evaluation, and Consequences of Linear Block at the Left Atrial Roof in Paroxysmal Atrial Fibrillation: A Prospective Randomized Study, Circulation, vol.112, issue.24, pp.3688-3696, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.541052

G. Fassini, S. Riva, R. Chiodelli, N. Trevisi, M. Berti et al., Left Mitral Isthmus Ablation Associated with PV Isolation: Long-Term Results of a Prospective Randomized Study, Journal of Cardiovascular Electrophysiology, vol.10, issue.11, pp.1150-1156, 2005.
DOI : 10.1046/j.1540-8167.2004.04055.x

H. Oral, A. Chugh, E. Good, S. Sankaran, S. Reich et al., A Tailored Approach to Catheter Ablation of Paroxysmal Atrial Fibrillation, Circulation, vol.113, issue.15, pp.1824-1831, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.601898

M. Haissaguerre, M. Hocini, P. Sanders, F. Sacher, M. Rotter et al., Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias, Journal of Cardiovascular Electrophysiology, vol.16, issue.11, pp.1138-1147, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.491530

H. Oral, A. Chugh, E. Good, A. Wimmer, S. Dey et al., Radiofrequency Catheter Ablation of Chronic Atrial Fibrillation Guided by Complex Electrograms, Circulation, vol.115, issue.20, pp.2606-2612, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.691386

H. Oral, C. Scharf, A. Chugh, B. Hall, P. Cheung et al., Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation, Circulation, vol.108, issue.19, pp.2355-2360, 2003.
DOI : 10.1161/01.CIR.0000095796.45180.88

M. Karch, B. Zrenner, I. Deisenhofer, J. Schreieck, G. Ndrepepa et al., Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies, Circulation, vol.111, issue.22, pp.2875-2880, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.491530

B. Nilsson, X. Chen, S. Pehrson, L. Kober, J. Hilden et al., Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial versus the extraostial ablation strategy, American Heart Journal, vol.152, issue.3, pp.537-531, 2006.
DOI : 10.1016/j.ahj.2006.05.029

T. Arentz, R. Weber, G. Burkle, C. Herrera, T. Blum et al., Small or Large Isolation Areas Around the Pulmonary Veins for the Treatment of Atrial Fibrillation?: Results From a Prospective Randomized Study, Circulation, vol.115, issue.24, pp.3057-3063, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.690578

O. Wazni, N. Marrouche, D. Martin, A. Verma, M. Bhargava et al., Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation, JAMA, vol.293, issue.21, pp.2634-2640, 2005.
DOI : 10.1001/jama.293.21.2634

G. Stabile, E. Bertaglia, G. Senatore, D. Simone, A. Zoppo et al., Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)???, European Heart Journal, vol.27, issue.2, pp.216-221, 2006.
DOI : 10.1093/eurheartj/ehi583

P. Jais, B. Cauchemez, L. Macle, E. Daoud, P. Khairy et al., Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study, Circulation, vol.118, issue.24, pp.2498-2505, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.772582

H. Calkins, M. Reynolds, P. Spector, M. Sondhi, Y. Xu et al., Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses, Circulation: Arrhythmia and Electrophysiology, vol.2, issue.4, pp.349-361, 2009.
DOI : 10.1161/CIRCEP.108.824789

C. Pappone, G. Vicedomini, G. Augello, F. Manguso, M. Saviano et al., Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy: A Prospective, Randomized, 4-Year Follow-Up Trial: The APAF Study, Circulation: Arrhythmia and Electrophysiology, vol.4, issue.6, pp.808-814, 2011.
DOI : 10.1161/CIRCEP.111.966408

H. Kottkamp, G. Hindricks, C. Eitel, K. Muller, A. Siedziako et al., Deep Sedation for Catheter Ablation of Atrial Fibrillation: A Prospective Study in 650 Consecutive Patients, Journal of Cardiovascular Electrophysiology, vol.12, issue.12, pp.1339-1343, 2011.
DOI : 10.1093/europace/euq276

R. Bubien, J. Fisher, J. Gentzel, E. Murphy, M. Irwin et al., NASPE Expert Consensus Document: Use of IV (Conscious) Sedation/Analgesia by Nonanesthesia Personnel in Patients Undergoing Arrhythmia Specific Diagnostic, Therapeutic, and Surgical Procedures, Pacing and Clinical Electrophysiology, vol.81, issue.2, pp.375-385, 1998.
DOI : 10.1016/S0031-3955(16)38690-4

J. Ren, F. Marchlinski, and D. Callans, Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography, Journal of the American College of Cardiology, vol.43, issue.10, pp.1861-1867, 2004.
DOI : 10.1016/j.jacc.2004.01.031

S. Asbach, J. Biermann, C. Bode, and T. Faber, Early Heparin Administration Reduces Risk for Left Atrial Thrombus Formation during Atrial Fibrillation Ablation Procedures, Cardiology Research and Practice, vol.8, issue.6, p.615087, 2011.
DOI : 10.1016/j.hrthm.2011.01.020

C. Bruce, P. Friedman, O. Narayan, T. Munger, S. Hammill et al., Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation, Journal of Interventional Cardiac Electrophysiology, vol.106, issue.3, pp.211-219, 2008.
DOI : 10.1016/j.jacc.2006.09.033

U. Dorwarth, M. Fiek, T. Remp, C. Reithmann, M. Dugas et al., Radiofrequency Catheter Ablation:. Different Cooled and Noncooled Electrode Systems Induce Specific Lesion Geometries and Adverse Effect Profiles, Pacing and Clinical Electrophysiology, vol.100, issue.7p1, pp.1438-1445, 2003.
DOI : 10.1161/01.CIR.100.7.768

A. Waldo, D. Wilber, F. Marchlinski, W. Stevenson, B. Aker et al., Safety of the Open-Irrigated Ablation Catheter for Radiofrequency Ablation: Safety Analysis from Six Clinical Studies, Pacing and Clinical Electrophysiology, vol.104, issue.9, 2012.
DOI : 10.1016/j.amjcard.2009.04.040

V. Reddy, D. Shah, J. Kautzner, B. Schmidt, N. Saoudi et al., The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the toccata study Heart Rhythm, 2012.

S. Vazquez, S. Johnson, and M. Rondina, Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation, Thrombosis Research, vol.126, issue.2, pp.69-77, 2010.
DOI : 10.1016/j.thromres.2009.11.031

V. Mardigyan, A. Verma, D. Birnie, P. Guerra, D. Redfearn et al., Anticoagulation Management Pre- and Post Atrial Fibrillation Ablation: A Survey of Canadian Centres, Canadian Journal of Cardiology, vol.29, issue.2, 2012.
DOI : 10.1016/j.cjca.2012.04.013

D. Shah, Filamentous thrombi during left-sided sheath-assisted catheter ablations, Europace, vol.15, issue.3, pp.1657-1658, 2010.
DOI : 10.1161/CIRCEP.109.859116

D. Snipelisky, C. Kauffman, K. Prussak, G. Johns, K. Venkatachalam et al., A comparison of bleeding complications post-ablation between warfarin and dabigatran, Journal of Interventional Cardiac Electrophysiology, vol.59, issue.13, 2012.
DOI : 10.1016/j.jacc.2011.12.014

K. Kaseno, S. Naito, K. Nakamura, T. Sakamoto, T. Sasaki et al., Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation, Circulation Journal, vol.76, issue.10, p.2012
DOI : 10.1253/circj.CJ-12-0498

R. Weerasooriya, P. Khairy, J. Litalien, L. Macle, M. Hocini et al., Catheter Ablation for Atrial Fibrillation, Journal of the American College of Cardiology, vol.57, issue.2, pp.160-166, 2011.
DOI : 10.1016/j.jacc.2010.05.061

M. Hystad, O. Geiran, H. Attramadal, A. Spurkland, A. Vege et al., Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure, Acta Physiologica Scandinavica, vol.84, issue.4, pp.395-403, 2001.
DOI : 10.1161/01.CIR.84.4.1581

P. Mccullough and G. Fonarow, B-type natriuretic peptide and multimarker approaches in cardiovascular medicine, Rev Cardiovasc Med, vol.4, pp.1-2, 2003.

T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo, A new natriuretic peptide in porcine brain, Nature, vol.332, issue.6159, pp.78-81, 1988.
DOI : 10.1038/332078a0

H. Brunner-la-rocca, D. Kaye, R. Woods, J. Hastings, and M. Esler, Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects, Journal of the American College of Cardiology, vol.37, issue.5, pp.1221-1227, 2001.
DOI : 10.1016/S0735-1097(01)01172-X

J. Araujo, A. Azevedo, P. Lourenco, F. Rocha-goncalves, A. Ferreira et al., Intraindividual Variation of Amino-Terminal Pro-B-Type Natriuretic Peptide Levels in Patients With Stable Heart Failure, The American Journal of Cardiology, vol.98, issue.9, pp.1248-1250, 2006.
DOI : 10.1016/j.amjcard.2006.06.017

K. Thygesen, J. Mair, C. Mueller, K. Huber, M. Weber et al., Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care, European Heart Journal, vol.35, issue.10, pp.2001-2006, 2012.
DOI : 10.1097/01.CCM.0000284509.23439.5B

A. Jaffe, L. Babuin, and F. Apple, Biomarkers in Acute Cardiac Disease, Journal of the American College of Cardiology, vol.48, issue.1, pp.1-11, 2006.
DOI : 10.1016/j.jacc.2006.02.056

A. Maisel, C. Mueller, K. Adams, J. Anker, S. Aspromonte et al., State of the art: Using natriuretic peptide levels in clinical practice, European Journal of Heart Failure, vol.350, issue.8, pp.824-839, 2008.
DOI : 10.1056/NEJMoa031994

P. Porapakkham, H. Zimmet, B. Billah, and H. Krum, B-Type Natriuretic Peptide???Guided Heart Failure Therapy, Archives of Internal Medicine, vol.170, issue.6, pp.507-514, 2010.
DOI : 10.1001/archinternmed.2010.35

R. Berger, D. Moertl, S. Peter, R. Ahmadi, M. Huelsmann et al., N-Terminal Pro???B-Type Natriuretic Peptide???Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure, Journal of the American College of Cardiology, vol.55, issue.7, pp.645-653, 2010.
DOI : 10.1016/j.jacc.2009.08.078

R. Ababsa, P. Jourdain, F. Funck, P. Deschamps, and N. Sadeg, [bnp and dyspnea: Proposition of a diagnostic strategy based on two cut-off], Ann Biol Clin, vol.63, pp.213-216, 2005.

J. Mcmurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Bohm et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Developed in collaboration with the heart failure association (hfa) of the esc, pp.1787-1847, 2012.
DOI : 10.1016/j.repce.2013.10.001

H. Silvet, Y. Young-xu, D. Walleigh, and S. Ravid, Brain natriuretic peptide is elevated in outpatients with atrial fibrillation, The American Journal of Cardiology, vol.92, issue.9, pp.1124-1127, 2003.
DOI : 10.1016/j.amjcard.2003.07.010

Y. Kaji, T. Miyoshi, M. Doi, S. Hirohata, S. Kamikawa et al., Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation, Hypertension Research, vol.89, issue.7, pp.611-616, 2009.
DOI : 10.1161/01.CIR.89.2.724

A. Morello, D. Lloyd-jones, C. Chae, R. Van-kimmenade, A. Chen et al., Association of atrial fibrillation and amino-terminal pro???brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study, American Heart Journal, vol.153, issue.1, pp.90-97, 2007.
DOI : 10.1016/j.ahj.2006.10.005

S. Inoue, Y. Murakami, K. Sano, H. Katoh, and T. Shimada, Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation, Journal of Cardiac Failure, vol.6, issue.2, pp.92-96, 2000.
DOI : 10.1016/S1071-9164(00)90010-1

Y. Ohta, T. Shimada, H. Yoshitomi, S. Inoue, Y. Murakami et al., Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation, Can J Cardiol, vol.17, pp.415-420, 2001.

C. Vinch, J. Rashkin, G. Logsetty, D. Tighe, J. Hill et al., Brain Natriuretic Peptide Levels Fall Rapidly after Cardioversion of Atrial Fibrillation to Sinus Rhythm, Cardiology, vol.102, issue.4, pp.188-193, 2004.
DOI : 10.1159/000081009

M. Nakamura, H. Niinuma, M. Chiba, K. Ueshima, N. Arakawa et al., Effect of the Maze Procedure for Atrial Fibrillation on Atrial and Brain Natriuretic Peptide, The American Journal of Cardiology, vol.79, issue.7, pp.966-970, 1997.
DOI : 10.1016/S0002-9149(97)00023-4

P. Gould, L. Gula, V. Bhayana, R. Subbiah, C. Bentley et al., Characterization of Cardiac Brain Natriuretic Peptide Release in Patients With Paroxysmal Atrial Fibrillation Undergoing Left Atrial Ablation, Circulation: Arrhythmia and Electrophysiology, vol.3, issue.1, pp.18-23, 2010.
DOI : 10.1161/CIRCEP.108.831586

W. Tillett and T. Francis, SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS, Journal of Experimental Medicine, vol.52, issue.4, pp.561-571, 1930.
DOI : 10.1084/jem.52.4.561

A. Pradhan, J. Manson, N. Rifai, J. Buring, and P. Ridker, C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus, JAMA, vol.286, issue.3, pp.327-334, 2001.
DOI : 10.1001/jama.286.3.327

L. , D. Liu, K. Tian, L. Greenland, and P. , Narrative review: Assessment of c-reactive protein in risk prediction for cardiovascular disease, Ann Intern Med, vol.145, pp.35-42, 2006.

D. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand, C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force, Annals of Internal Medicine, vol.151, issue.7, pp.483-495, 2009.
DOI : 10.7326/0003-4819-151-7-200910060-00009

J. Cao, A. Arnold, T. Manolio, J. Polak, B. Psaty et al., Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study, Circulation, vol.116, issue.1, pp.32-38, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.645606

E. Choi, R. Yan, V. Fernandes, A. Opdahl, A. Gomes et al., High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: The multiethnic study of atherosclerosis, American Heart Journal, vol.164, issue.2, pp.251-258, 2012.
DOI : 10.1016/j.ahj.2012.05.010

W. Yin, J. Chen, H. Jen, M. Chiang, W. Huang et al., Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure, American Heart Journal, vol.147, issue.5, pp.931-938, 2004.
DOI : 10.1016/j.ahj.2003.11.021

N. Lamblin, F. Mouquet, B. Hennache, J. Dagorn, S. Susen et al., High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure, European Heart Journal, vol.26, issue.21, pp.2245-2250, 2005.
DOI : 10.1161/01.CIR.102.6.611

J. Dernellis and M. Panaretou, C-reactive protein and paroxysmal atrial fibrillation, Acta Cardiologica, vol.56, issue.6, pp.375-380, 2001.
DOI : 10.2143/AC.56.6.2005701

M. Chung, D. Martin, D. Sprecher, O. Wazni, A. Kanderian et al., C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation, Circulation, vol.104, issue.24, pp.2886-2891, 2001.
DOI : 10.1161/hc4901.101760

O. Wazni, D. Martin, N. Marrouche, M. Shaaraoui, M. Chung et al., C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion, Heart, vol.91, issue.10, pp.1303-1305, 2005.
DOI : 10.1136/hrt.2004.038661

P. Korantzopoulos, T. Kolettis, E. Kountouris, V. Dimitroula, P. Karanikis et al., Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation, International Journal of Cardiology, vol.102, issue.2, pp.321-326, 2005.
DOI : 10.1016/j.ijcard.2004.12.041

D. Conway, P. Buggins, E. Hughes, and G. Lip, Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation, The American Journal of Cardiology, vol.94, issue.4, pp.508-510, 2004.
DOI : 10.1016/j.amjcard.2004.04.070

M. Ozaydin, Atrial fibrillation and inflammation, World Journal of Cardiology, vol.2, issue.8, pp.243-250, 2010.
DOI : 10.4330/wjc.v2.i8.243

L. Macle, P. Khairy, A. Verma, R. Weerasooriya, S. Willems et al., Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination (ADVICE): Methods and Rationale, Canadian Journal of Cardiology, vol.28, issue.2, pp.184-190, 2012.
DOI : 10.1016/j.cjca.2011.10.008

S. Matsuo, T. Yamane, T. Date, N. Lellouche, K. Tokutake et al., Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation, American Heart Journal, vol.161, issue.1, pp.188-196, 2011.
DOI : 10.1016/j.ahj.2010.10.016

Y. Khaykin, X. Wang, A. Natale, O. Wazni, A. Skanes et al., Cost Comparison of Ablation Versus Antiarrhythmic Drugs As First-Line Therapy for Atrial Fibrillation: An Economic Evaluation of the RAAFT Pilot Study, Journal of Cardiovascular Electrophysiology, vol.285, issue.8A, pp.7-12, 2009.
DOI : 10.1161/01.CIR.98.10.946

E. Bertaglia, C. Tondo, D. Simone, A. Zoppo, F. Mantica et al., Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience, Europace, vol.1, issue.19, pp.181-187, 2010.
DOI : 10.1161/01.CIR.0000146917.75041.58

J. Kang, D. Lee, S. Kim, M. Kim, Y. Park et al., Prediction of Long-Term Outcomes of Catheter Ablation of Persistent Atrial Fibrillation by Parameters of Preablation DC Cardioversion, Journal of Cardiovascular Electrophysiology, vol.118, issue.11, 2012.
DOI : 10.1161/CIRCULATIONAHA.108.772582

L. Calo, F. Lamberti, M. Loricchio, D. Ruvo, E. Colivicchi et al., Left Atrial Ablation Versus Biatrial Ablation for Persistent and Permanent Atrial Fibrillation, Journal of the American College of Cardiology, vol.47, issue.12, pp.2504-2512, 2006.
DOI : 10.1016/j.jacc.2006.02.047

Y. Nagamoto, J. Park, D. Tanubudi, Y. Ko, J. Ban et al., Clinical Significance of Induced Atrial Tachycardia After Termination of Longstanding Persistent Atrial Fibrillation Using a Stepwise Approach, Journal of Cardiovascular Electrophysiology, vol.7, issue.11, 2012.
DOI : 10.1016/j.hrthm.2010.01.009

E. Heist, F. Chalhoub, C. Barrett, S. Danik, J. Ruskin et al., Predictors of Atrial Fibrillation Termination and Clinical Success of Catheter Ablation of Persistent Atrial Fibrillation, The American Journal of Cardiology, vol.110, issue.4
DOI : 10.1016/j.amjcard.2012.04.028

Y. Park, J. Choi, H. Lim, S. Park, and Y. Kim, Is Pursuit of Termination of Atrial Fibrillation During Catheter Ablation of Great Value in Patients with Longstanding Persistent Atrial Fibrillation?, Journal of Cardiovascular Electrophysiology, vol.22, issue.Suppl 1, 2012.
DOI : 10.1111/j.1540-8167.2011.02108.x

P. Wang, J. Dong, D. Long, M. Ning, R. Tang et al., Impact of different termination modes on atrial fibrillation termination in catheter ablation of persistent atrial fibrillation, Chin Med J (Engl), vol.125, pp.1877-1883, 2012.

C. Rolfes, S. Howard, R. Goff, and P. Iaizzo, Cardiac remodeling as a consequence of atrial fibrillation: An anatomical study of perfusion-fixed human heart specimens, J Geriatr Cardiol, vol.8, pp.141-146, 2011.

R. Troughton and A. Richards, B-Type Natriuretic Peptides and Echocardiographic Measures of Cardiac Structure and Function, JACC: Cardiovascular Imaging, vol.2, issue.2, pp.216-225, 2009.
DOI : 10.1016/j.jcmg.2008.12.006

Y. Akutsu, K. Kaneko, Y. Kodama, J. Suyama, H. Li et al., Association Between Left and Right Atrial Remodeling With Atrial Fibrillation Recurrence After Pulmonary Vein Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Pilot Study, Circulation: Cardiovascular Imaging, vol.4, issue.5, pp.524-531, 2011.
DOI : 10.1161/CIRCIMAGING.110.962761

J. Zhuang, Y. Wang, K. Tang, X. Li, W. Peng et al., Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies, Europace, vol.97, issue.8, pp.638-645, 2012.
DOI : 10.1016/j.amjcard.2005.11.043

M. Jaubert, S. Armero, L. Bonello, A. Nicoud, P. Sbragia et al., Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: An echocardiographic-catheterization study, Archives of Cardiovascular Diseases, vol.103, issue.1, pp.3-9, 2010.
DOI : 10.1016/j.acvd.2009.10.005

S. Lee, J. Jung, S. Choi, N. Lee, W. Park et al., Determinants of Brain Natriuretic Peptide Levels in Patients With Lone Atrial Fibrillation, Circulation Journal, vol.70, issue.1, pp.100-104, 2006.
DOI : 10.1253/circj.70.100

B. Nilsson, J. Goetze, X. Chen, S. Pehrson, and J. Svendsen, Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation, Scandinavian Journal of Clinical and Laboratory Investigation, vol.97, issue.8, pp.843-850, 2009.
DOI : 10.1016/j.amjcard.2005.12.071

E. Solheim, M. Off, P. Hoff, D. Bortoli, A. Schuster et al., N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation, Journal of Interventional Cardiac Electrophysiology, vol.112, issue.2, pp.129-136, 2012.
DOI : 10.1161/CIRCULATIONAHA.104.518837

P. Jais, M. Vergnes, P. Nurden, Y. Takahashi, P. Sanders et al., Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the find-af study Decline in c-reactive protein after successful ablation of longlasting persistent atrial fibrillation, PLoS One. J Am Coll Cardiol, vol.747, pp.1231-1233, 2006.

K. Lemola, B. Hall, P. Cheung, E. Good, J. Han et al., Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation, Heart Rhythm, vol.1, issue.2, pp.197-202, 2004.
DOI : 10.1016/j.hrthm.2004.03.071

E. Gerstenfeld, D. Callans, S. Dixit, E. Zado, and F. Marchlinski, Incidence and Location of Focal Atrial Fibrillation Triggers in Patients Undergoing Repeat Pulmonary Vein Isolation:, Journal of Cardiovascular Electrophysiology, vol.105, issue.7, pp.685-690, 2003.
DOI : 10.1161/01.CIR.101.14.1736

D. Callans, E. Gerstenfeld, S. Dixit, E. Zado, M. Vanderhoff et al., Efficacy of Repeat Pulmonary Vein Isolation Procedures in Patients with Recurrent Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, vol.104, issue.9, pp.1050-1055, 2004.
DOI : 10.1161/01.CIR.0000095796.45180.88

S. Mainigi, W. Sauer, J. Cooper, S. Dixit, E. Gerstenfeld et al., Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation After Ablation, Journal of Cardiovascular Electrophysiology, vol.102, issue.1, pp.69-74, 2007.
DOI : 10.1046/j.1540-8167.2005.04407.x

M. Casella, G. Pelargonio, D. Russo, A. Riva, S. Bartoletti et al., ???Near-zero??? fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX??? mapping system: personal experience and review of the literature, Journal of Interventional Cardiac Electrophysiology, vol.157, issue.4, pp.109-118, 2011.
DOI : 10.1016/j.ahj.2008.08.009

P. Pellegrino, N. Brunetti, D. Gravina, D. Sacchetta, V. Sanctis et al., Nonfluoroscopic mapping reduces radiation exposure in ablation of atrial fibrillation, Journal of Cardiovascular Medicine, vol.14, issue.7, p.2012
DOI : 10.2459/JCM.0b013e328356a4e6

P. Sanders, M. Hocini, P. Jais, F. Sacher, L. Hsu et al., Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome???, European Heart Journal, vol.109, issue.15, pp.1862-1871, 2007.
DOI : 10.1161/01.CIR.0000131866.44650.46

H. Oral, A. Chugh, M. Ozaydin, E. Good, J. Fortino et al., Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation, Circulation, vol.114, issue.8, pp.759-765, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.641225

A. Guiot, K. Jongnarangsin, A. Chugh, A. Suwanagool, R. Latchamsetty et al., Anticoagulant Therapy and Risk of Cerebrovascular Events After Catheter Ablation of Atrial Fibrillation in the Elderly, Journal of Cardiovascular Electrophysiology, vol.20, issue.1, pp.36-43, 2012.
DOI : 10.2188/jea.JE20090186

H. Klemm, R. Ventura, T. Rostock, B. Brandstrup, T. Risius et al., Correlation of Symptoms to ECG Diagnosis Following Atrial Fibrillation Ablation, Journal of Cardiovascular Electrophysiology, vol.347, issue.2, pp.146-150, 2006.
DOI : 10.1046/j.1540-8167.2004.03371.x

C. Vasamreddy, D. Dalal, J. Dong, A. Cheng, D. Spragg et al., Symptomatic and Asymptomatic Atrial Fibrillation in Patients Undergoing Radiofrequency Catheter Ablation, Journal of Cardiovascular Electrophysiology, vol.89, issue.2, pp.134-139, 2006.
DOI : 10.1046/j.1540-8167.2004.04052.x

G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J. Gerds-li et al., Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence, Circulation, vol.112, issue.3, pp.307-313, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.518837

H. Oral, S. Veerareddy, E. Good, B. Hall, P. Cheung et al., Prevalence of Asymptomatic Recurrences of Atrial Fibrillation After Successful Radiofrequency Catheter Ablation, Journal of Cardiovascular Electrophysiology, vol.26, issue.8, pp.920-924, 2004.
DOI : 10.1161/01.STR.26.9.1527

N. Dagres, H. Kottkamp, C. Piorkowski, S. Weis, A. Arya et al., Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation, International Journal of Cardiology, vol.139, issue.3, pp.305-306, 2010.
DOI : 10.1016/j.ijcard.2008.10.004

C. Eitel, D. Husser, G. Hindricks, M. Fruhauf, S. Hilbert et al., Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis, Europace, vol.9, issue.9, pp.480-485, 2011.
DOI : 10.1093/europace/eum106

M. Kuhne, B. Schaer, P. Ammann, Y. Suter, S. Osswald et al., Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation, Swiss Med Wkly, vol.140, pp.214-221, 2010.

M. Kuhne, Y. Suter, D. Altmann, P. Ammann, B. Schaer et al., Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: Biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns, Heart Rhythm, vol.7, issue.12, pp.1770-1776, 2010.
DOI : 10.1016/j.hrthm.2010.08.028

P. Defaye, A. Kane, A. Chaib, and P. Jacon, Efficacy and safety of pulmonary veins isolation by cryoablation for the treatment of paroxysmal and persistent atrial fibrillation, Europace, vol.6, issue.7, pp.789-795, 2011.
DOI : 10.1016/j.hrthm.2009.03.051

E. Gerstenfeld, New Technologies for Catheter Ablation of Atrial Fibrillation, Current Treatment Options in Cardiovascular Medicine, vol.54, issue.15, pp.393-401, 2011.
DOI : 10.1016/j.jacc.2009.07.009